H Jonathan Groot1, Ryan M Broxterman2,3, Jayson R Gifford4, Ryan S Garten5, Matthew J Rossman6, Catherine L Jarrett2,3, Oh Sung Kwon7, Jay R Hydren2,8, Russell S Richardson2,3,8. 1. Department of Health & Kinesiology University of Utah, Salt Lake City, Utah, USA. 2. Geriatric Research, Education, and Clinical Center, Salt Lake City, Utah, VAMC, USA. 3. Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. 4. Department of Exercise Sciences, Brigham Young University, Provo, Utah, USA. 5. Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia, USA. 6. Department of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado, USA. 7. Department of Kinesiology, University of Connecticut, Storrs, Connecticut, USA. 8. Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, USA.
Abstract
NEW FINDINGS: What is the central question of this study? Use of the passive leg movement (PLM) test, a non-invasive assessment of microvascular function, is on the rise. However, PLM reliability in men has not been adequately investigated, nor has such reliability data, in men, been compared to the most commonly employed vascular function assessment, flow-mediated vasodilation (FMD). What is the main finding and its importance? PLM is a reliable method to assess vascular function in men, and is comparable to values previously reported for PLM in women, and for FMD. Given the importance of vascular function as a predictor of cardiovascular disease risk, these data support the utility of PLM as a clinically relevant measurement. ABSTRACT: Although vascular function is an independent predictor of cardiovascular disease risk, and therefore has significant prognostic value, there is currently not a single clinically accepted method of assessment. The passive leg movement (PLM) assessment predominantly reflects microvascular endothelium-dependent vasodilation and can identify decrements in vascular function with advancing age and pathology. Reliability of the PLM model was only recently determined in women, and has not been adequately investigated in men. Twenty healthy men (age: 27 ± 2 year) were studied on three separate experimental days, resulting in three within-day and three between-day trials. The hyperemic response to PLM was assessed with Doppler ultrasound, and expressed as the absolute peak in leg blood flow (LBFpeak ), change from baseline to peak (ΔLBFpeak ), absolute area under the curve (LBFAUC ), and change in AUC from baseline (ΔLBFAUC ). PLM-induced hyperemia yielded within-day coefficients of variation (CV) from 10.9 to 22.9%, intraclass correlation coefficients (ICC) from 0.82 to 0.90, standard error of the measurement (SEM) from 8.3 to 17.2%, and Pearson's correlation coefficients (r) from 0.56 to 0.81. Between-day assessments of PLM hyperemia resulted in CV from 14.4 to 25%, ICC from 0.75 to 0.87, SEM from 9.8 to 19.8%, and r from 0.46 to 0.75. Similar to previous reports in women, the hyperemic responses to PLM in men display moderate-to-high reliability, and are comparable to reliability data for brachial artery flow mediated vasodilation. These positive reliability findings further support the utility of PLM as a clinical measurement of vascular function and cardiovascular disease risk.
NEW FINDINGS: What is the central question of this study? Use of the passive leg movement (PLM) test, a non-invasive assessment of microvascular function, is on the rise. However, PLM reliability in men has not been adequately investigated, nor has such reliability data, in men, been compared to the most commonly employed vascular function assessment, flow-mediated vasodilation (FMD). What is the main finding and its importance? PLM is a reliable method to assess vascular function in men, and is comparable to values previously reported for PLM in women, and for FMD. Given the importance of vascular function as a predictor of cardiovascular disease risk, these data support the utility of PLM as a clinically relevant measurement. ABSTRACT: Although vascular function is an independent predictor of cardiovascular disease risk, and therefore has significant prognostic value, there is currently not a single clinically accepted method of assessment. The passive leg movement (PLM) assessment predominantly reflects microvascular endothelium-dependent vasodilation and can identify decrements in vascular function with advancing age and pathology. Reliability of the PLM model was only recently determined in women, and has not been adequately investigated in men. Twenty healthy men (age: 27 ± 2 year) were studied on three separate experimental days, resulting in three within-day and three between-day trials. The hyperemic response to PLM was assessed with Doppler ultrasound, and expressed as the absolute peak in leg blood flow (LBFpeak ), change from baseline to peak (ΔLBFpeak ), absolute area under the curve (LBFAUC ), and change in AUC from baseline (ΔLBFAUC ). PLM-induced hyperemia yielded within-day coefficients of variation (CV) from 10.9 to 22.9%, intraclass correlation coefficients (ICC) from 0.82 to 0.90, standard error of the measurement (SEM) from 8.3 to 17.2%, and Pearson's correlation coefficients (r) from 0.56 to 0.81. Between-day assessments of PLM hyperemia resulted in CV from 14.4 to 25%, ICC from 0.75 to 0.87, SEM from 9.8 to 19.8%, and r from 0.46 to 0.75. Similar to previous reports in women, the hyperemic responses to PLM in men display moderate-to-high reliability, and are comparable to reliability data for brachial artery flow mediated vasodilation. These positive reliability findings further support the utility of PLM as a clinical measurement of vascular function and cardiovascular disease risk.
Authors: Lorenzo Ghiadoni; Francesco Faita; Massimo Salvetti; Carlo Cordiano; Almerina Biggi; Massimo Puato; Antonio Di Monaco; Luca De Siati; Massimo Volpe; Giuseppe Ambrosio; Vincenzo Gemignani; Maria L Muiesan; Stefano Taddei; Gaetano A Lanza; Francesco Cosentino Journal: J Hypertens Date: 2012-07 Impact factor: 4.844
Authors: Melissa A Hayman; Jose N Nativi; Josef Stehlik; John McDaniel; Anette S Fjeldstad; Stephen J Ives; D Walter Wray; Feras Bader; Edward M Gilbert; Russell S Richardson Journal: Am J Physiol Heart Circ Physiol Date: 2010-09-10 Impact factor: 4.733
Authors: H Jonathan Groot; Joel D Trinity; Gwenael Layec; Matthew J Rossman; Stephen J Ives; Russell S Richardson Journal: Am J Physiol Heart Circ Physiol Date: 2012-12-21 Impact factor: 4.733
Authors: M Venturelli; M Amann; G Layec; J McDaniel; J D Trinity; A S Fjeldstad; S J Ives; G Yonnet; R S Richardson Journal: Acta Physiol (Oxf) Date: 2013-11-05 Impact factor: 6.311
Authors: H Jonathan Groot; Joel D Trinity; Gwenael Layec; Matthew J Rossman; Stephen J Ives; David E Morgan; Amber Bledsoe; Russell S Richardson Journal: J Physiol Date: 2015-07-27 Impact factor: 5.182
Authors: H Jonathan Groot; Matthew J Rossman; Ryan S Garten; Eivind Wang; Jan Hoff; Jan Helgerud; Russell S Richardson Journal: Med Sci Sports Exerc Date: 2016-08 Impact factor: 5.411
Authors: Salim S Virani; Alvaro Alonso; Hugo J Aparicio; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Susan Cheng; Francesca N Delling; Mitchell S V Elkind; Kelly R Evenson; Jane F Ferguson; Deepak K Gupta; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Chong D Lee; Tené T Lewis; Junxiu Liu; Matthew Shane Loop; Pamela L Lutsey; Jun Ma; Jason Mackey; Seth S Martin; David B Matchar; Michael E Mussolino; Sankar D Navaneethan; Amanda Marma Perak; Gregory A Roth; Zainab Samad; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Andrew Stokes; Lisa B VanWagner; Nae-Yuh Wang; Connie W Tsao Journal: Circulation Date: 2021-01-27 Impact factor: 29.690
Authors: Alon Peretz; Daniel F Leotta; Jeffrey H Sullivan; Carol A Trenga; Fiona N Sands; Mary R Aulet; Marla Paun; Edward A Gill; Joel D Kaufman Journal: BMC Cardiovasc Disord Date: 2007-03-21 Impact factor: 2.298